Scientific Company Directory

Sino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers obtain the best reagents in the needed amounts to accelerate the pace of discovery and improve human health.

Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results. By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to accelerate your discoveries. Our goal is to bring a unique perspective to the flow cytometry tools required for in-depth single cell isolation and analysis. With our core expertise in automation and software development we hope to enable discovery research across immunology, oncology, cell biology and microbiology.

AB SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company's global leadership and world-class service & support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery & development, food & environmental testing, forensics and clinical research. With over 40 years of proven innovation, AB SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis.

Fluidigm creates and manufactures innovative technologies and life-science tools designed to revolutionize biology through a relentless pursuit of scientific truth. Its core technologies are based on microfluidics and mass cytometry, and enable the exploration and analysis of individual cells, as well as the industrial application of genomics.

Shimadzu Corporation has remained committed to commercializing cutting-edge technology and providing it to customers in a wide array of industries for more than 140 years.

Synthego's vision is to turn biology into an information science, with the ultimate goal of dramatically extending the healthy human lifespan. Synthego builds advanced bioinformatics and automated hardware platforms to create next-generation molecular biology tools, starting with full-stack genome engineering. These world-class tools accelerate basic scientific discovery, critical disease cures and novel synthetic biology applications to improve and prolong life.

Sebia is the world's leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies.

sphingotec GmbH aims to develop diagnostic methods for prediction, prevention, intervention strategies and early treatment of diseases in the fields of cancer, cardiovascular diseases and kidney function. In order to realize this mission we provide biomarkers indicating susceptibility for a specific disease which enables the monitoring of prevention and intervention strategies. The company was established in 2002 by Dr. Andreas Bergmann who is one of the founders and managers of B.R.A.H.M.S. Aktiengesellschaft where, in addition to several other biomarkers, the sepsis marker Procalcitonin (B.R.A.H.M.S PCT®) was developed in his role as Chief Research Officer. This biomarker Procalcitonin created a new diagnostic standard of care supporting patient management in sepsis. sphingotec is located in Hennigsdorf, northwest of Berlin, Germany, with its facilities in the Technology Campus one of the largest industrial parks in Berlin and Brandenburg with several companies of the biotechnology branch located there.

STEMCELL Technologies Inc. is a Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research. Driven by science and a passion for quality, STEMCELL supports the advancement of scientific research around the world with our catalogue of more than 2000 cell biology research tools. STEMCELL Technologies was launched in 1993 when founder and CEO Allen Eaves needed a way to meet the increasing demands for his standardized, cost-effective cell culture media for growing blood-forming stem cells. At the time, Eaves was a hematologist and cancer researcher heading the Terry Fox Laboratories (TFL) and head of clinical hematology at the University of British Columbia in Vancouver, Canada. Unsatisfied with commercially available cell culture reagents, Eaves' research group at the TFL began making their own hematopoietic stem cell culture media using the highest quality materials they could find. Colleagues also wanted to use this media, and Eaves was able to supplement his research funds by selling culture media to other lab groups. Eventually the demand for the media from researchers around the world warranted building a designated clean room for production. The TFL did not have the funding and instead, Eaves was encouraged to purchase the business and create an independent company. Mortgaging his house and receiving a loan from Western Economic Diversification, Eaves was able to build a clean room and STEMCELL Technologies Inc. was born on July 2, 1993. STEMCELL has become the largest biotech company in Canada and continues to reinvest all profits back into developing products to better support the international research community. As of 2017, the company employs more than 1000 people globally, with over one-third of those holding a PhD or MSc, and the majority of employees having a BSc or Engineering degree. A large number of the company's employees are located in Vancouver, Canada with additional employees and facilities in 11 other countries.

seqWell was created to revolutionize NGS library prep to unlock the full potential of today's DNA sequencing instruments. Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes. In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.

The Society of Laboratory Animal Veterinary Technicians (SLAVT) is a group focused on National recognition through training and certification for veterinary technicians in the field of laboratory animal medicine. This goal was achieved with the creation of the Veterinary Technician Specialty (VTS) Academy of Laboratory Animal Veterinary Technicians and Nurses (ALAVTN). It is the mission of SLAVT is to enhance animal welfare; sharing of clinical, surgical and technical ideas amongst its membership, continuing education, and professional networking among laboratory animal technicians. This mission is shared with ALAVTN with the main focus to promote excellence by specialization in veterinary technology/nursing in the distinct field of Laboratory Animal Medicine by demonstrating advance proficiency of skill level and knowledge base.

Scicasts is a data technology and media company that connects science professionals and decision makers to a dynamic network of critical information, new ideas and cross-sector intelligence. Our team is pioneering the concept of cognitive computing that provides our community an alternative access to research papers, R&D news, industry analytics and journal citations within seconds.

SomaLogic® was founded in 2000 by Larry Gold, with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed. Building on the previous decade of aptamer research, SomaLogic scientists have developed a new proteomics technology that overcomes the significant challenges of current technologies, and which has multiple applications across the biological and medical sciences. Our mission is to leverage our proprietary technology to discover, develop and commercialize revolutionary new life science research tools and breakthrough clinical diagnostic products that will transform healthcare.

StressMarq Biosciences is a life sciences company with a diverse portfolio of primary antibodies, proteins, immunoassay kits and small molecules for scientific research in areas including cancer research, cardiovascular disease, cell signaling and neuroscience. StressMarq has recently developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research, including proteins such as alpha synuclein, tau, SOD1 and TTR. Our strategic efforts are currently focused on being a world leader in the manufacturing and marketing of fibrilized proteins (and their derivatives), protein oligomers, and antibodies to fibrilizing proteins to assist researchers studying Alzheimer's, Parkinson's, and other neurodegenerative diseases.

System Biosciences (SBI) develops innovative research tools for MicroRNA research, Exosome research, and Genome Engineering tools, including the CRISPR-Cas9 SmartNuclease system and PrecisionX HR targeting vectors. SBIs ExoQuick Exosome precipitation reagent is the most highly published reagent for exosome isolation in the world, with dozens of product citations in top journals. SBI also specializes in biomarker discovery with our unique Exo-NGS service, offering an end-to-end solution starting with patient samples and delivering comprehensive data analytics on NGS sequencing of exosomal RNA libraries.

Sysmex is the recognized, global leader of in vitro diagnostic hematology systems. Our corporate mission is to shape the advancement of healthcare and we accomplish this by partnering in academic and industrial research and through clinical diagnostics. Our expertise in cellular analysis, from counting to identification, results in our industry-leading technologies utilizing flow cytometry and fluorescence. Sysmex is committed to advancements in flow cytometry, building upon our hematology knowledge and strengthened by our acquisition of Partec GmbH, a pioneer in flow cytometry. Our comprehensive line of flow cytometry products includes analyzers (CyFlow® Cube and CyFlow® Space), consumables (CellTrics® filters) and reagents (CyFlow™ monoclonal antibodies, lysing solutions).